Who
Elizabeth Rozek
Chief Legal & Admin. Officer
Company insider
Files Form 4 as: Chief Legal & Admin. Officer, Sagimet Biosciences.
In numbers
- Trades disclosed
- 19
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $324K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Jul 2023
- Last trade
- 20 Jul 2026
- Last filed
- 22 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Jul 2026filed 22 Jul 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Sold | $82K10,545 at $7.76 | filing |
| 20 Jul 2026filed 22 Jul 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Sold | $82K10,545 at $7.76 | filing |
| 28 May 2026filed 1 Jun 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —88,000 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —88,000 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Sold | $14K2,622 at $5.36 | filing |
| 10 Feb 2026filed 12 Feb 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Sold | $14K2,622 at $5.36 | filing |
| 4 Nov 2025filed 6 Nov 2025 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,367 at $0.00 | filing |
| 4 Nov 2025filed 6 Nov 2025 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code A | —9,855 at $0.00 | filing |
| 21 Jul 2025filed 23 Jul 2025 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Sold | $98K10,780 at $9.13 | filing |
| 6 Feb 2025filed 7 Feb 2025 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —138,000 at $0.00 | filing |
| 6 Feb 2025filed 7 Feb 2025 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code A | —34,000 at $0.00 | filing |
| 19 Jul 2024filed 23 Jul 2024 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Sold | $34K10,914 at $3.10 | filing |
| 17 Nov 2023filed 21 Nov 2023 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code A | —171,420 at $0.00 | filing |
| 18 Jul 2023filed 20 Jul 2023 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —242,142 at $0.00 | filing |
| 18 Jul 2023filed 20 Jul 2023 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —242,142 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.